What is the ticker symbol for Contineum Therapeutics?

Contineum Therapeutics trades under the ticker CTNM on NASDAQ.

What sector does Contineum Therapeutics operate in?

Contineum Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CTNM in a portfolio?

PortView shows CTNM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Contineum Therapeutics (CTNM) Stock Analysis

NASDAQHealthcareBiotechnology

$16.82+1.63%

1-year price historyRange $9.17 – $17.25

52-week range$16.82

$8.60$17.51

What Contineum Therapeutics does

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.

Key metrics

Market cap

$632.79M

P/E (TTM)

-9.72

EPS (TTM)

$-1.73

Beta

0.74

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$15.08

200-day avg

$13.41

52-week high

$17.51

52-week low

$8.60

CEO

Carmine N. Stengone

ETFs linked to CTNM

Broad-market and Healthcare sector ETFs an investor holding Contineum Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CTNM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CTNM in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Contineum Therapeutics?: Contineum Therapeutics trades under the ticker CTNM on NASDAQ.
Which exchange is CTNM listed on?: CTNM is listed on NASDAQ.
What sector does Contineum Therapeutics operate in?: Contineum Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CTNM in a portfolio?: PortView shows CTNM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.